Abstract
ΔN-p63 isoforms may act as oncogenes owing to their ability to bind to p53-reporter genes without inciting their transcription, thus blocking the p53-driven cell cycle arrest and apoptosis. A novel mechanism linking p63 and Wnt pathways has recently been proposed. Brieflyin vitro studies using squamous cell carcinoma cell lines have suggested that ΔN-p63 may block the phosphorylation of β-catenin, leading to its nuclear accumulation and triggering β-catenin-responsive transcription of genes related to proliferation and oncogenic biological behavior. To test this new mechanism, the co-expression of ΔN-p63 and β-catenin was evaluated in a large cohort of human neoplasms.Two serial sections of TARP-4 multi-tumor tissue microarray, composed of 51 normal tissue cores and 400 human neoplasms [breast (n=75), colon (n=75), lung (n=75), prostate (n=75) and ovary (n=50) neoplasms, melanoma (n=25), and glioblastoma (n=25)] were subjected to immunohistochemistry with ΔN-p63 and β-catenin monoclonal antibodies. p63 nuclear expression and β-catenin membranous, cytoplasmic, membranous+cytoplasmic, and nuclear localization were evaluated.ΔN-p63 expression and β-catenin nuclear localization were found in 92.6% and 0% of squamous cell carcinomas, 8.9% and 0% of breast carcinomas, 13.8% and 0% of lung adenocarcinomas, 1.4% and 23.2% of colon adenocarcinomas, 0% and 4.8% of prostate adenocarcinomas, 11.1% and 5% of ovary carcinomas, 9.0% and 9.1% of malignant melanomas, and 12.5% and 40.0% of glioblastomas, respectively. No statistically significant association between ΔN-p63 and nuclear β-catenin expression was found for all tumors.At variance with squamous cell carcinoma cell lines, p63-driven nuclear accumulation of β-catenin is an unusual phenomenon in human neoplasms. Caution should be exercised when translating the results of studies performed on cell lines to human neoplasms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.